Progyny, Inc. (NASDAQ:PGNY – Get Rating) CEO Peter Anevski sold 16,000 shares of Progyny stock in a transaction on Monday, June 5th. The stock was sold at an average price of $40.00, for a total transaction of $640,000.00. Following the sale, the chief executive officer now directly owns 215,924 shares of the company’s stock, valued […]
Progyny, Inc. (NASDAQ:PGNY – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price objective among brokerages that have […]
Progyny, Inc. (NASDAQ:PGNY – Get Rating) CEO Peter Anevski sold 32,000 shares of the firm’s stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $36.30, for a total value of $1,161,600.00. Following the transaction, the chief executive officer now directly owns 215,924 shares in the company, valued […]
Progyny, Inc. (NASDAQ:PGNY – Get Rating) CEO Peter Anevski sold 32,000 shares of the business’s stock in a transaction that occurred on Friday, May 12th. The stock was sold at an average price of $36.30, for a total transaction of $1,161,600.00. Following the completion of the transaction, the chief executive officer now owns 215,924 shares […]
Envestnet Asset Management Inc. lifted its stake in Progyny, Inc. (NASDAQ:PGNY – Get Rating) by 45.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 174,963 shares of the company’s stock after purchasing an additional 54,258 shares during the period. Envestnet Asset Management Inc.’s […]